Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 244,550 | 190,129 | 122,451 | 66,241 | 282,122 |
| Depreciation Amortization | 21,383 | 16,101 | 10,654 | 5,071 | 18,597 |
| Income taxes - deferred | 7,584 | -2,076 | 302 | 2,930 | 12,262 |
| Accounts receivable | 3,971 | 38,025 | 12,628 | 40,102 | -31,413 |
| Accounts payable and accrued liabilities | -6,202 | N/A | -12,139 | N/A | 9,881 |
| Other Working Capital | 10,649 | 33,492 | 129 | 16,932 | 37,182 |
| Other Operating Activity | -10,330 | -53,663 | -10,667 | -48,672 | -4,922 |
| Operating Cash Flow | $271,605 | $222,008 | $123,358 | $82,604 | $323,709 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -269,769 | -233,393 | -116,494 | -9,070 | 217,135 |
| PPE Investments | -26,610 | -19,350 | -13,603 | -7,969 | -27,018 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | 70,685 |
| Purchase Sale Intangibles | -1,783 | -1,016 | -45 | -30 | -3,666 |
| Other Investing Activity | -1,783 | -1,016 | -45 | -30 | -3,666 |
| Investing Cash Flow | $-298,162 | $-253,759 | $-130,142 | $-17,069 | $257,136 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -26,984 | -26,827 | N/A | N/A | -88,849 |
| Dividend Paid | N/A | N/A | N/A | N/A | -500,000 |
| Financing Cash Flow | $-26,984 | $-26,827 | $N/A | $N/A | $-588,849 |
| Exchange Rate Effect | -556 | 488 | N/A | N/A | -1,156 |
| Beginning Cash Position | 567,451 | 567,451 | 567,451 | 567,451 | 576,611 |
| End Cash Position | 513,354 | 509,361 | 560,667 | 632,986 | 567,451 |
| Net Cash Flow | $-54,097 | $-58,090 | $-6,784 | $65,535 | $-9,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | 271,605 | 222,008 | 123,358 | 82,604 | 323,709 |
| Capital Expenditure | -26,631 | -19,350 | -13,603 | -7,969 | -26,992 |
| Free Cash Flow | 244,974 | 202,658 | 109,755 | 74,635 | 296,717 |